Valentina M.
- Country
- Italy
- Department
- Hematolgy and Oncology
Research Overview
- Evaluation of Ponatinib Combined with Chemotherapy in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Efficacy of Ponatinib and Blinatumomab Versus Chemotherapy and Imatinib in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Evaluation of Ponatinib, Alone or with Chemotherapy, for Minimal Residual Disease and Hematologic Relapse in Adult Ph+ Acute Lymphoblastic Leukemia
Data & Insights
Has run more than one trial at 55 of 109 partner sites.
Specializations
Acute Lymphoblastic Leukemia Research
The investigator specializes in treating various subtypes of Acute Lymphoblastic Leukemia (ALL), with particular expertise in Philadelphia chromosome-positive and Philadelphia chromosome-negative ALL.
- Ph-like ALL Treatment Innovation
- T-cell ALL Management
- Molecular Response Assessment
Their work encompasses novel therapeutic approaches combining targeted therapies with conventional treatments.
Myeloid Leukemia Studies
The investigator focuses on advancing treatment options for Acute Myeloid Leukemia (AML), particularly in cases involving specific genetic alterations.
- KMT2A and NPM1 Mutations
- Elderly AML Patient Care
- Novel Combination Therapies
Their research extends to chemotherapy-free treatment approaches for specific patient populations.
Treatment Resistance Studies
The investigator addresses challenging cases of refractory and relapsed leukemia, focusing on innovative treatment strategies.
- Minimal Residual Disease Management
- Novel Drug Combinations
- Treatment Response Monitoring
Their work includes developing approaches for patients who have not achieved remission with conventional treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.